Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Image processing apparatus, image display apparatus, and image processing method
Pre-distortion architecture for compensating non-linear effects
Mirac proteins
Switchgear and method for operating switchgear
Headset, terminal, and method capable of switching headset mode
Case for electronic device
Maize hybrid X08B748
  Randomly Featured Patents
Low-profile MEMS thermal printhead die having backside electrical connections
One-component toner for dry electrophotography containing metal complex as charge control agent
Endoscope and front cover
Search center dynamic configuration using field mappings
Non-reciprocal circuit element
Pressurized squeegee with stiff resilient sealing strips
Construction toy with connectable portions
Air conditioner
PhoH homolog